Composition comprising a pulmonary surfactant and a PDE2 inhibitor

Details for Australian Patent Application No. 2004268387 (hide)

International Classifications

Event Publications

13 April 2006 PCT application entered the National Phase

PCT publication WO2005/021037 Priority application(s): WO2005/021037

23 November 2006 Amendment Made

The nature of the amendment is: Amend the name of the inventor from Wollin, Stefan-Lutz? to Wollin, Stefan-Lutz

30 November 2006 Change of Name(s) of Applicant(s), Section 104

ALTANA Pharma AG? The name of the applicant has been changed to ALTANA Pharma AG

22 November 2007 Change of Name(s) of Applicant(s), Section 104

ALTANA Pharma AG The name of the applicant has been changed to Nycomed GmbH

5 June 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.